Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
The New England journal of medicine · 2022 · 867 citations · Boadie Dunlop
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
JAMA · 2023 · 408 citations · Boadie Dunlop
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.
Journal of affective disorders · 2023 · 125 citations · Boadie Dunlop
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
Journal of affective disorders · 2025 · 36 citations · Boadie Dunlop
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes.
Journal of clinical psychopharmacology · 2025 · 31 citations · Sandarsh Surya
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes.
Journal of clinical psychopharmacology · 2025 · 29 citations ·
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial.
Molecular psychiatry · 2024 · 48 citations · William McCall
The metabolome-wide signature of major depressive disorder.
Molecular psychiatry · 2024 · 48 citations · Boadie Dunlop